Association of limited scleroderma and pulmonary hypertension in a patient with primary biliary cirrhosis

Journal of Nippon Medical School

Volumn 72, Issue 4, 2005, Pages 230-235

  Katsuta, Yasumi ^a   Higashi, Haruka ^a   Zhang, Xue Jun ^a   Kato, Yoshihito ^a   Shimizu, Shuji ^a   Komeichi, Hirokazu ^a   Ohsuga, Masaru ^a   Satomura, Katsuaki ^a   Takano, Teruo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Endothelin 1; Hepatopulmonary syndrome; Intrapulmonary vasodilatation; Nitric oxide; Thromboxane B 2

Indexed keywords

THROMBOXANE A2; THROMBOXANE B2;

AGED; ARTICLE; CAPILLARY PRESSURE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; FINGER; HEART CATHETERIZATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIMITED SCLERODERMA; LIVER HISTOLOGY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NEEDLE BIOPSY; PHYSICAL EXAMINATION; PRIMARY BILIARY CIRRHOSIS; PULMONARY HYPERTENSION; SKIN; THORAX RADIOGRAPHY; THORAX WALL;

AGED; HUMANS; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS, BILIARY; MALE; SCLERODERMA, LIMITED;

EID: 25144450017     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.72.230     Document Type: Article

References (32)

1. Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, Black CM, Coghlan JG: Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 461-466.
2. Battle RW, Davitt MA, Cooper SM, Buckley LM, Leib ES, Beglin PA, Tischler MD: Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110: 1515-1519.
3. Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H Jr, Bein M, Smith JW, Roberts N, Cabeen W: Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75: 65-74.
4. Salerni R, Rodnan GP, Leon DF, Shaver JA: Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977; 86: 394-399.
5. MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coghlan J, Black CM: Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001; 40: 453-459.
6. Yousem SA: The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990; 21: 467-474.
7. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-1093.
8. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr: Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515-524.
9. Clarke AK, Galbraith RM, Hamilton EBD, Williams R: Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 1978; 37: 42-47.
10. Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER: Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982; 57: 365-370.
11. Marie I, Levesque H, Tranvouez JL, Francois A, Riachi G, Cailleux N, Courtois H: Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) 2001; 40: 102-106.
12. Reynolds TB, Denison EK, Frankl HD, Lieberman FL, Peters RL: Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med 1971; 50: 302-312.
13. Marasini B, Gagetta M, Rossi V, Ferrari P: Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001; 60: 1046-1049.
14. Watt FE, James OF, Jones DE: Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004; 97: 397-406.
15. Shoji I, Takagi T, Kasukawa R: Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis. Intern Med 1992; 31: 1348-1355.
16. Bernstein RM, Callender ME, Neuberger JM, Hughes GR, Williams R: Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 1982; 41: 612-614.
17. Swanson KL, Krowka MJ: Arterial oxygenation associated with portopulmonary hypertension. Chest 2002; 121: 1869-1875.
18. Budhiraja R, Hassoun PM: Portopulmonary hypertension: a tale of two circulations. Chest 2003; 123: 562-576.
19. Katsuta Y, Zhang X-J, Kato Y, Shimizu S, Komeichi K, Ohsuga M, Higashi H, Satomura K, Takano T: Hemodynamic features and impaired arterial oxygenation in patients with protopulmonary hypertension. Hepatol Res in press.
20. D'Angelo WA, Fries JF, Masi AT, Shulman LE: Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-440.
21. Guttadauria M, Ellman H, Emmanuel G, Kaplan D, Diamond H: Pulmonary function in scleroderma. Arthritis Rheum 1977; 20: 1071-1079.
22. Owens GR, Fino GJ, Herbert DL, Steen VD, Medsger TA Jr, Pennock BE, Cottrell JJ, Rodnan GP, Rogers RM: Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983; 84: 546-550.
23. West JB, Wagner PD: Ventilation, blood flow, and gas exchange. In Textbook of respiratory medicine (Murray JF, Nadel JA, eds), 2000; pp 55-89, W.B. Saunders, Philadelphia.
24. Hoeper MM, Krowka MJ, Strassburg CP: Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363: 1461-1468.
25. Zhang XJ, Shimizu S, Nagato T, Komeichi H, Ohsuga M, Terada H, Sekiyama T, Satomura K, Katsuta Y, Aramaki T : Hemodynamic characteristics of portopulmonary hypertension: An evaluation of five patients. Jpn J of Portal Hypertension 1999; 5: 67-72.
26. Suzuki K, Kamata N, Inokuma S, Terada H, Yokoyama Y, Abi K, Mochizuki T, Kobayashi T: Clinical significance of ventilation/perfusion scans in collagen disease patients. Ann Nucl Med 2000; 14: 405-413.
27. Langleben D, Christman BW, Barst RJ, Dias VC, Galie N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Soler M: Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J 2002; 143: E4.
28. Cacoub P, Dorent R, Nataf P, Carayon A, Riquet M, Noe E, Piette JC, Godeau P, Gandjbakhch I: Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997; 33: 196-200.
29. Langleben D, Christman BW, Barst RJ, Dias VC, Galie N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Soler M: Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J 2002; 143: e4.
30. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE: An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engle J Med 1992; 327: 70-75.
31. Sakamoto K, Houya I, Inoue K, Tanaka M, Suzuki T, Sakamoto Y, Matsuo H: An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm. Eur Respir J 1999; 13: 137-144.
32. Zhang XJ, Katsuta Y, Akimoto T, Ohsuga M, Aramaki T, Takano T: Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol 2003; 39: 724-730.